Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Relationship of plasminogen activator inhibitor 1 gene 4G/5G polymorphisms to hypertension in Korean women.

Kim KN, Kim KM, Kim BT, Joo NS, Cho DY, Lee DJ.

Chin Med J (Engl). 2012 Apr;125(7):1249-53.

3.

Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes.

Margaglione M, Grandone E, Vecchione G, Cappucci G, Giuliani N, Colaizzo D, Celentano E, Panico S, Di Minno G.

Arterioscler Thromb Vasc Biol. 1997 Oct;17(10):2082-7.

4.

Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure.

Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T.

Am J Hypertens. 2011 Jul;24(7):802-8. doi: 10.1038/ajh.2011.63. Epub 2011 Apr 14.

PMID:
21490692
5.
6.

[Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome].

Guan LX, Du XY, Wang JX, Wang RL, Wu ZL, Jiang H.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2004 Apr;21(2):173-5. Chinese.

PMID:
15079805
8.
9.

4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.

Chen CH, Eng HL, Chang CJ, Tsai TT, Lai ML, Chen HY, Liu CJ, Lin TM.

J Lab Clin Med. 2003 Aug;142(2):100-5.

PMID:
12960956
10.

[Plasminogen activator inhibitor-1 (PAI-1) 4G/5G and angiotensin converting enzyme (ACE) I/D gene polymorphisms and fibrinolytic activity in patients with essential hypertension and dyslipidemia].

Jastrzebska M, Widecka K, Ciechanowicz A, Goracy I, Wesołowska T, Torbus-Lisiecka B, Foltyńska-Nowakowska A, Naruszewicz M.

Pol Arch Med Wewn. 2005 Jan;113(1):7-20. Polish.

PMID:
16130596
11.

4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.

Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.

Thromb Haemost. 1998 Dec;80(6):956-60.

PMID:
9869167
12.
13.

The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.

Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR.

Thromb Haemost. 1998 May;79(5):975-9.

PMID:
9609232
14.

[Association of plasminogen activator inhibitor-1 gene 4G/5G polymorphism and coronary heart disease in Chinese patients].

Guan L, Ji X, Wang J, Zhang A, Zhang Y, Zhao L.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Oct;19(5):393-6. Chinese.

PMID:
12362314
15.

Diabetic retinopathy, promoter (4G/5G) polymorphism of PAI-1 gene, and PAI-1 activity in Pima Indians with type 2 diabetes.

Nagi DK, McCormack LJ, Mohamed-Ali V, Yudkin JS, Knowler WC, Grant PJ.

Diabetes Care. 1997 Aug;20(8):1304-9.

PMID:
9250459
16.

The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

Lin S, Huiya Z, Bo L, Wei W, Yongmei G.

Endocrine. 2009 Dec;36(3):503-9. doi: 10.1007/s12020-009-9255-2. Epub 2009 Oct 24.

PMID:
19856137
17.

Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.

Martínez-Calatrava MJ, González-Sánchez JL, Zabena C, Martínez-Larrad MT, Luque-Otero M, Serrano-Ríos M.

J Hypertens. 2007 Apr;25(4):773-7.

PMID:
17351368
18.

The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease.

Margaglione M, Cappucci G, Colaizzo D, Giuliani N, Vecchione G, Grandone E, Pennelli O, Di Minno G.

Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):152-6.

19.

Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G/5G) associated with obesity and vascular risk in children.

Berberoğlu M, Evliyaoğlu O, Adiyaman P, Ocal G, Ulukol B, Simşek F, Siklar Z, Törel A, Ozel D, Akar N.

J Pediatr Endocrinol Metab. 2006 May;19(5):741-8.

PMID:
16789641
20.

Genotype frequency of plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism in healthy Japanese males and its relation to PAI-1 levels.

Matsubara Y, Murata M, Isshiki I, Watanabe R, Zama T, Watanabe G, Watanabe K, Ikeda Y.

Int J Hematol. 1999 Jan;69(1):43-7.

PMID:
10641442
Items per page

Supplemental Content

Write to the Help Desk